Cargando…
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend
BACKGROUND: Due to the arrival of multi-valent HPV vaccines, it is more and more important to have a better understanding of the relationship between vaccination and screening programmes. This review aimed to: (1) collect published evidence on the cost-effectiveness profile of different HPV preventi...
Autores principales: | Gervais, Frédéric, Dunton, Kyle, Jiang, Yiling, Largeron, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371248/ https://www.ncbi.nlm.nih.gov/pubmed/28351348 http://dx.doi.org/10.1186/s12889-017-4076-3 |
Ejemplares similares
-
A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
por: Bresse, Xavier, et al.
Publicado: (2013) -
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
por: Marty, Rémi, et al.
Publicado: (2013) -
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017) -
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
por: Kulasingam, Shalini L, et al.
Publicado: (2008) -
Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
por: Östensson, Ellinor, et al.
Publicado: (2015)